Consistency of cell culture media (CCM) is vital for reliable therapeutic protein production, as media variability can adversely affect cell growth and drug quality. Comprehensive media identity is key to ensuring lot-to-lot comparability. However, current quality control methods often leave many media components unverified, introducing risks into the manufacturing process. This webinar presents a CCM fingerprinting approach for comprehensive media characterization. It is optimized to quantify as many components as possible, ensuring proper identity testing prior to release, significantly increase cell growth, and quickly troubleshoot media performance issues.
In this webinar, you will learn:
- Why current CCM identity tests are incomplete for media release
- How a single analytical method detects ~75% of media components
- How media component coverage of ~90% can be achieved, ensuring comprehensive identification of critical media components
- Real-world use cases showing application of the method to significantly improve cell culture media performance
Speaker
Jude Lakbub
Merck
R&D Manager, Cell Culture Media Analytics, Upstream & Process Materials R&D
Jude Lakbub is an upstream R&D manager at Merck. With a Ph.D. in analytical chemistry from the University of Kansas and an M.S. from East Tennessee State University, Jude has more than nine years of experience in analytical method development for cell culture media and biologics characterization. Jude leads a Cell Culture Media Analytics Team that supports media development and customer investigations through advanced analytical characterization of cell culture media.
Pharma and biopharma manufacturing
- Pharma and biopharma manufacturing
Duration:1h
Language:English
Session 1:Tue, November 4, 2025 4:00 PM CEST
To continue reading please sign in or create an account.
Don't Have An Account?